Agios Pharmaceuticals AGIO
NASDAQ AGIO
$33.19 +0.06 (+0.18%)
As of: Sep 4, 2026 · 3:13 PM EDT

Agios Pharmaceuticals (AGIO) Operating Margin Growth (5y) (2017 - 2025)

Analysis

Agios Pharmaceuticals (AGIO) Operating Margin Growth (5y) (2017 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.51 Bn 130.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.24 Bn 77.25 Bn 3.93 Bn
3 Argenx Se 63.46 Bn 58.28 Bn 1.37 Bn
4 Moderna 57.89 Bn 52.75 Bn 52.00 Mn
5 Revolution Medicines 44.02 Bn 44.02 Bn -
6 BeOne Medicines 39.95 Bn 34.85 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.49 Bn 32.19 Bn 992.69 Mn
8 Royalty Pharma 28.43 Bn 27.59 Bn -
9 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
10 Agios Pharmaceuticals 1.97 Bn 1.97 Bn 41.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -39,903.00
Sep 30, 2025 -67,602.00
Jun 30, 2025 -79,717.00
Mar 31, 2025 -112,205.00
Dec 31, 2024 -86,641.00
Sep 30, 2024 -72,786.00
Jun 30, 2024 -79,405.00
Mar 31, 2024 -80,183.00
Dec 31, 2023 -117,518.00
Sep 30, 2023 -71,119.00
Jun 30, 2023 -121,550.00
Mar 31, 2023 -54,254.00
Dec 31, 2022 -138,119.00
Sep 30, 2022 -189,503.00
Jun 30, 2022 -100,356.00
Mar 31, 2022 -1.15 Mn
Dec 31, 2020 32,826.00
Sep 30, 2020 50,725.00
Jun 30, 2020 2,013.00
Mar 31, 2020 -8,473.00